Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients

被引:0
|
作者
Forsythe, J [1 ]
机构
[1] Royal Infirm, Transplant Unit, Edinburgh EH3 9YW, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:69S / 71S
页数:3
相关论文
共 50 条
  • [1] Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients
    Vanrenterghem, Y
    Squifflet, JP
    Forsythe, J
    Heeman, U
    Bäckman, L
    Taube, D
    Morales, JM
    Ekberg, H
    van Hooff, J
    Zanker, B
    Dietl, KH
    Talbot, D
    Hauser, I
    Tydén, G
    Claesson, K
    Mühlbacher, F
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1290 - 1291
  • [2] Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients
    Miller, J
    Mendez, R
    Pirsch, JD
    Jensik, SC
    [J]. TRANSPLANTATION, 2000, 69 (05) : 875 - 880
  • [3] Randomized trial of tacrolimus in combination with mycophenolate mofetil versus cyclosporine with mycophenolate mofetil in cadaveric renal transplant recipients with delayed graft function
    Liu, B
    Lin, ZB
    Ming, CS
    Zhang, WJ
    Chen, ZS
    Sha, B
    Zeng, FJ
    Chen, S
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (01) : 87 - 88
  • [4] Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients
    Squifflet, JP
    Bäckman, L
    Claesson, K
    Dietl, KH
    Ekberg, H
    Forsythe, JLR
    Kunzendorf, U
    Heemann, U
    Land, W
    Morales, JM
    Mühlbacher, F
    Talbot, D
    Taube, D
    Tyden, G
    van Hooff, J
    Schleibner, S
    Vanrenterghem, Y
    [J]. TRANSPLANTATION, 2001, 72 (01) : 63 - 69
  • [5] A Comparison of Mycophenolate Mofetil With Mycophenolate Sodium in Renal Transplant Recipients on Tacrolimus-Based Treatment
    Aptaramanov, B.
    Seyahi, N.
    Alagoz, S.
    Pekmezci, S.
    Ataman, R.
    Tasci, H.
    Serdengecti, K.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (03) : 833 - 836
  • [6] Effect of aclizumab, tacrolimus, and mycophenolate mofetil in pediatric first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Mattiazzi, A
    Rosen, A
    Zilleruello, G
    Abitbol, C
    Montane, B
    Miller, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1944 - 1945
  • [7] Economic contribution of prophylactic immunosuppressive therapy with mycophenolate mofetil in renal cadaveric transplant recipients
    LouisTouizer, C
    Nuijten, MJC
    Bayle, F
    Cantarovich, D
    Lang, P
    Lebranchu, Y
    LePogamp, P
    Touraine, JL
    Vialtel, P
    Monroe, T
    deVries, MJ
    [J]. PRESSE MEDICALE, 1996, 25 (33): : 1577 - 1582
  • [8] Delayed graft function with and without mycophenolate mofetil in cadaveric renal transplant recipients.
    Fabrizii, V
    Kaiser, A
    Mittermayer, C
    Muellner, M
    Woisetschlaeger, C
    Steiniger, R
    Muehlbacher, F
    Hoerl, WH
    Pohanka, E
    [J]. TRANSPLANTATION, 2000, 69 (08) : S329 - S329
  • [9] Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients
    Ciancio, G
    Burke, GW
    Suzart, K
    Roth, D
    Kupin, W
    Rosen, A
    Gomez, C
    Mattiazzi, A
    Esquenazi, V
    Miller, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1617 - 1618
  • [10] Primary immunosuppression with tacrolimus and low-dose mycophenolate mofetil in renal transplant recipients
    Yeung, S
    Tsang, WK
    Tong, KL
    Wong, SH
    Lee, W
    Tang, HL
    Chan, HWH
    Chan, AYW
    [J]. TRANSPLANTATION PROCEEDINGS, 2004, 36 (07) : 2084 - 2086